The External Exposome and COVID-19 Severity
The External Exposome and COVID-19 Severity
批准号:
10531662
负责人:
Jiang Bian
金额:
$23.27万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-12-15 至 2024-07-31
中文摘要
项目摘要
2019年新型冠状病毒病(COVID-19)是一场全球性大流行病,严重影响了医疗和社会经济发展。
后果没有任何潜在健康状况的年轻人仍然可能发展为严重的COVID-19
在COVID-19住院率和死亡率方面存在种族和民族差异,
不能仅仅用年龄和潜在的健康状况来解释。严重COVID-19的风险因素超出
老年人和潜在的健康状况在很大程度上是未知的。目前,
严重COVID-19的已知风险因素以及受环境影响的健康状况
暴露,新的证据表明,长期的环境暴露可能是重要的
COVID-19严重程度的决定因素。传统的环境流行病学研究通常检查
环境因素单独考虑,而不考虑“外部环境的整体性”。此类研究
不仅耗时,因为他们分别检查个人暴露,但更重要的是,
考虑到共同暴露的混杂。外部困境是小说识别的理想框架
因为它可以系统有效地筛查成千上万的
环境暴露。在这个项目中,我们将利用一个独特的真实世界数据(RWD)资源-
OneFlorida -一个大型的链接电子健康记录(EHR),索赔和生命统计数据库,
覆盖超过60%的佛罗里达州,为国家以患者为中心的临床研究网络做出贡献
(PCORnet)。在我们先前关于外部麻烦的工作的基础上,我们将扩大我们现有的外部
复杂的数据库,包括可能通过系统性评估影响COVID-19结果的其他因素
分析文献和资源。我们的目标是(1)开发用于识别COVID-19的表型分析算法
队列及其严重程度,并从OneFlorida现实世界中提取相关的个人水平风险因素
数据,以及(2)识别与严重COVID-19相关的外部麻烦因素,研究外部因素如何影响
在严重的COVID-19中,麻烦导致种族和民族差异,并建立预测模型,
严重的COVID-19和外部麻烦因素。这项研究将填补重要的知识空白,提供
及时的信息,以了解环境暴露如何影响COVID-19的严重程度,
改善对高风险COVID-19患者的识别,并为未来精确干预措施的设计提供信息。
我们的方法和佛罗里达的初步结果可以(1)通过PCORnet容易地扩展到多州研究
和(2)回答其他新的问题,如外部麻烦的贡献,地理差距,
COVID-19结果。
英文摘要
PROJECT SUMMARY
The 2019 novel coronavirus disease (COVID-19) is a global pandemic with severe medical and socioeconomic
consequences. Young adults without any underlying health conditions can still develop severe COVID-19
disease, and there are racial and ethnic disparities in COVID-19 hospitalization and mortality rates which
cannot be explained by age and underlying health conditions alone. Risk factors of severe COVID-19 beyond
older age and underlying health conditions are large unknown. There are large overlaps between the currently
known risk factors of severe COVID-19 and the health conditions that are affected by environmental
exposures, and emerging evidence suggested that long-term environmental exposures may be important
determinants of COVID-19 severity. Traditional environmental epidemiological studies usually examine
environmental factors separately without considering “the totality of the external environment”. Such studies
are not only time consuming as they examine individual exposures separately, but more importantly, cannot
account for confounding by co-exposures. The external exposome is an ideal framework to identify novel
exposures associated with severe COVID-19 as it can systematically and efficiently screen thousands of
environmental exposures. In this project, we will leverage a unique real-world data (RWD) resource –
OneFlorida – a large repository of linked electronic health records (EHR), claims and vital statistics data,
covering more than 60% of Floridians, contributing to the national Patient-Centered Clinical Research Network
(PCORnet). Building on our prior work on the external exposome, we will expand our existing external
exposome database to include additional factors that may impact COVID-19 outcomes through a systematic
analysis of literature and resources. We aim to (1) develop phenotyping algorithms for identifying a COVID-19
cohort and their severity and extracting associated individual-level risk factors from the OneFlorida real-world
data, and (2) identify external exposome factors associated with severe COVID-19, examine how the external
exposome contributes to racial and ethnic disparities in severe COVID-19, and build predictive models of
severe COVID-19 with external exposome factors. This study will fill important knowledge gaps by providing
timely information to understand how environmental exposures may impact COVID-19 severity that will
improve identifications of high-risk COVID-19 patients and inform the design of future precision interventions.
Our approach and initial results for Florida can (1) be readily scaled up to a multi-state study through PCORnet
and (2) answer other novel questions such as the external exposome’s contribution to geographic disparities in
COVID-19 outcomes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.envres.2021.111185
发表时间:
2021-06
期刊:
Environmental research
影响因子:
8.3
作者:
[Zhang H, Hu H, Diller M, Hogan WR, Prosperi M, Guo Y, Bian J]
通讯作者:
Bian J
DOI:
10.1016/j.scitotenv.2021.150352
发表时间:
2022-02-01
期刊:
The Science of the total environment
影响因子:
--
作者:
[Fishe J, Zheng Y, Lyu T, Bian J, Hu H]
通讯作者:
Hu H
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
-
批准号:10753675
-
项目类别:
-
资助金额:$115.53万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Disparities of Alzheimer's disease progression in sexual and gender minorities
-
批准号:10590413
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
-
批准号:10751275
-
项目类别:
-
资助金额:$256.15万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)
-
批准号:10699171
-
项目类别:
-
资助金额:$73.14万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
-
批准号:10728800
-
项目类别:
-
资助金额:$116.82万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
-
批准号:10682237
-
项目类别:
-
资助金额:$234.89万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
-
批准号:10752848
-
项目类别:
-
资助金额:$55.65万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI
-
批准号:10608470
-
项目类别:
-
资助金额:$82.02万
-
财政年份:2023
-
负责人:Jiang Bian
-
依托单位:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
-
批准号:10576853
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
-
批准号:10392169
-
项目类别:
-
资助金额:$80.75万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
-
批准号:10677539
-
项目类别:
-
资助金额:$119.57万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases
-
批准号:10368562
-
项目类别:
-
资助金额:$121.22万
-
财政年份:2022
-
负责人:Jiang Bian
-
依托单位:
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world Data
-
批准号:10374177
-
项目类别:
-
资助金额:$76.13万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Optimizing the Population Representativeness of Older Adults in Cancer Trials
-
批准号:10180066
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world Data
-
批准号:10330045
-
项目类别:
-
资助金额:$79.87万
-
财政年份:2021
-
负责人:Jiang Bian
-
依托单位:
Examine the risk of Alzheimer's disease in sexual and gender minorities
-
批准号:10283696
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
The External Exposome and COVID-19 Severity
-
批准号:10174270
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
Using Real-world Data to Assess the Burden of Diabetes in Children and Adolescents in Florida
-
批准号:10636657
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
The benefits and harms of lung cancer screening in Florida
-
批准号:10576300
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
Optimizing Alzheimer's Disease Clinical Trial Generalizability
-
批准号:10091637
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2020
-
负责人:Jiang Bian
-
依托单位:
海外基金